Lipitor Diabetes Lawsuits

lipitor-banner-170x250In early 2012, analysis of clinical trial results prompted the U.S. Food and Drug Administration (FDA) to change the labels of the cholesterol-reducing drug Lipitor to state that it increases a user’s risk of developing type-2 diabetes.

Patients who have taken Lipitor and developed type-2 diabetes have filed lawsuits against Pfizer, Lipitor’s manufacturer, for injuries caused by Lipitor’s potential side effects. These lawsuits are currently pending in courthouses throughout the country. Many of them allege that, way before 2012, Pfizer was aware of—but nevertheless failed to warn customers about—Lipitor’s propensity to increase serum glucose levels.

RLG’s Lipitor Lawyers Will Make Things Easier

Have you developed type-2 diabetes or some other harmful condition as a result of having taken Lipitor? If so, contact the Rottenstein Law Group by filling out the brief case evaluation form on your right.

The Lipitor lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a Lipitor lawsuit on your behalf if necessary. RLG will also keep you up to date on any Lipitor class action lawsuits, FDA Lipitor warnings, and Lipitor FDA recall announcements.

If you have taken Lipitor and believe it harmed you, contact RLG today.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.

*

  


− six = 2

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.